📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cell-Penetrating Peptide Conjugates of Steric Blocking Oligonucleotides as Therapeutics for Neuromuscular Diseases from a Historical Perspective to Current Prospects of Treatment. (2019)

First Author: Gait MJ

Attributed to: Peptide conjugated oligonucleotides for a phase I/IIa clinical trial in Spinal Muscular Atrophy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1089/nat.2018.0747

PubMed Identifier: 30307373

Publication URI: http://europepmc.org/abstract/MED/30307373

Type: Journal Article/Review

Volume: 29

Parent Publication: Nucleic acid therapeutics

Issue: 1

ISSN: 2159-3337